In this study, the clinical safety and toxicology of oral ingestion of supplement capsules containing ginseng radix was investigated in healthy young volunteers. This study was a pilot randomized, double blinded, placebo controlled trial. The healthy volunteers were divided into 6 groups of 20 each ...
In this study, the clinical safety and toxicology of oral ingestion of supplement capsules containing ginseng radix was investigated in healthy young volunteers. This study was a pilot randomized, double blinded, placebo controlled trial. The healthy volunteers were divided into 6 groups of 20 each (10 males and 10 females). They took the ginseng powder for 35 days (3g/day) for safety evaluation. There were measured general healthy levels such as hematological, biochemical and electrocardiographic parameters. After the first week, besides Korean white ginseng the other treatments led to an significant increase of white blood cells. Korean red ginseng increased UREA (blood urea nitrogen) in healthy volunteers, but it didn't exceed the range of normal values, and in the subsequent process of treatment there is no effect of elevating UREA. After the three weeks, Korean white ginseng showed relatively low the content of blood glucose and low-density lipoprotein cholesterol. After the five weeks, compared with the other treatments, Korean red ginseng increased white blood cells, platelet distribution width and average volume of platelet. Korean white ginseng decreased low-density lipoprotein cholesterol. American ginseng decreased blood creatinine in healthy volunteers. In conclusion, through test the blood routine, urine routine, liver function, renal function, blood glucose, blood lipid and electrocardiogram, the healthy volunteers continuous taking ginseng for 35 days (3 g/day) is safe and reliable, and have no obvious adverse reactions and side effects.
In this study, the clinical safety and toxicology of oral ingestion of supplement capsules containing ginseng radix was investigated in healthy young volunteers. This study was a pilot randomized, double blinded, placebo controlled trial. The healthy volunteers were divided into 6 groups of 20 each (10 males and 10 females). They took the ginseng powder for 35 days (3g/day) for safety evaluation. There were measured general healthy levels such as hematological, biochemical and electrocardiographic parameters. After the first week, besides Korean white ginseng the other treatments led to an significant increase of white blood cells. Korean red ginseng increased UREA (blood urea nitrogen) in healthy volunteers, but it didn't exceed the range of normal values, and in the subsequent process of treatment there is no effect of elevating UREA. After the three weeks, Korean white ginseng showed relatively low the content of blood glucose and low-density lipoprotein cholesterol. After the five weeks, compared with the other treatments, Korean red ginseng increased white blood cells, platelet distribution width and average volume of platelet. Korean white ginseng decreased low-density lipoprotein cholesterol. American ginseng decreased blood creatinine in healthy volunteers. In conclusion, through test the blood routine, urine routine, liver function, renal function, blood glucose, blood lipid and electrocardiogram, the healthy volunteers continuous taking ginseng for 35 days (3 g/day) is safe and reliable, and have no obvious adverse reactions and side effects.
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
문제 정의
We conducted collaboration research to resolve this issue with Jilin Agricultural University of China. The aim of this study was to evaluate the safety and toxicology of ginseng radix (P. ginseng, P. quinquefolium) delivered in capsule format in a randomized, double-blind, placebocontrolled study of closely monitored human subjects. The subject of experiment was Chinese young people.
제안 방법
The study was a double-blind, placebo-controlled study consisting of 5 weeks intervention. 120 healthy young volunteers of China (age range 21~25 years) were selected for this study.
It was referred to the data of Korea, China, Japan and USA (Ji and Lee, 1987; Nam and Park, 2000). The study outcome measures were also evaluated at the end of 1 week, 3 weeks and 5 weeks of treatment. All participants provided written informed consent prior to the start of the study.
However, these alterations were in normal ranges and they were not important clinically. Above this, we examined many items during the trial period, which are total cholesterol, triglyceride, high density lipoprotein cholesterol, direct bilirubin, total bilirubin, mean corpuscular hemoglobin, mean corpuscular, red cell distribution width standard deviation, alkaline phosphatase, gamma-glutamyl transpeptidase and carbon dioxide combining power, and there was no significant difference between the treatments (It was not given the data.). All the result of this study prove the food safety of Korean ginseng.
대상 데이터
4 years of Chinese white ginseng (P. ginseng, produced in China), 6 years of Chinese red ginseng (P. ginseng, produced in China) and 4 years of American ginseng (P. quinquefolium) were purchased from Ji’an city of Jilin Province.
quinquefolium) delivered in capsule format in a randomized, double-blind, placebocontrolled study of closely monitored human subjects. The subject of experiment was Chinese young people. The safety of Korean ginseng for them will contribute to consumer layer and demand expand of Korean ginseng in China.
The study was a double-blind, placebo-controlled study consisting of 5 weeks intervention. 120 healthy young volunteers of China (age range 21~25 years) were selected for this study. Before treatment, pulse rate and blood pressure readings were also taken, and a blood sample was taken for clinical examination and laboratory (hematology and blood biochemistry) investigations as well as urine analysis and electrocardiogram.
Volunteers were divided into 6 groups of 20 each (10 males and 10 females). Groups 1 received 3 g 4 years of Chinese white ginseng capsules, group 2 received 3 g 6 years of Chinese red ginseng capsules, group 3 received 3 g 4 years of Korean white ginseng capsules, group 4 received 3 g 6 years of Korean red ginseng capsules, group 5 received 3 g 4 years of American white ginseng capsules, group 6 received placebo (starch flour 3g), respectively, for 35 days.
데이터처리
Statistical analysis was done using Student’s paired t-test with SPSS software.
성능/효과
A once daily dose of different ginseng radix in capsule format taken over 5 weeks was used to demonstrate safety and toxicology in healthy young volunteers. In conclusion, through test the blood routine, urine routine, liver function, renal function, blood glucose, blood lipid and electrocardiogram, indicated that healthy volunteers continuous taking ginseng for 35 days (3 g/day) is safe and reliable, and have no obvious adverse reactions and side effects. This study also showed that ginseng radix may change some hematological and biochemical parameters.
참고문헌 (12)
Al-Gwaiz LA and Babay HH. (2007). The diagnostic value of absolute neutrophil count, band count and morphologic changes of neutrophils in predicting bacterial infections. Medical Principles and Practice. 16:344-347.
Fauci AS. (2011). Harrison's principles of internal medicine(18th ed.). p.611.
Han JS, Tak HS, Lee GS, Kim JS, Ra JW and Choi JE. (2013). Comparison of ginsenoside content and ratio of root tissue according to root age and diameter in Panax ginseng. Korean Journal of Medicinal Crop Science. 21:342-347.
Ji HJ and Lee SI. (1987). The Korean herbal pharmacopoeia of the Korean pharmacopoeia. Korean Medical Index. p.636.
Kim YC, Kim YB, Park HW, Bang KH, Kim JU, Cho IH, Kim KH, Song BH and Kim DH. (2014). Optimal harvesting time of ginseng seeds and effect of gibberellic acid( ${GA}_{3}$ ) treatment for improving stratification rate of ginseng(Panax ginseng C. A. Meyer) seeds. Korean Journal of Medicinal Crop Science. 22:423-428.
Daly ME, Vale C, Walker M, Littlefield A, Alberti KG and Mathers JC. (1998). Acute effects on insulin sensitivity and diurnal metabolic profiles of a high-sucrose compared with a high starch diet. American Journal of Clinical Nutrition. 67:1186-1196.
Mitchell LJ, Christopher JM, Erminia DP, Ryan RS and Satya PA. (2012). Evaluation of clinical safety and tolerance of a Lactobacillus reuteri NCIMB 30242 supplement capsule: A randomized control trial. Regulatory Toxicology and Pharmacology 63:313-320.
Murakawa M, Okamura T, Tsutsumi K, Tanoguchi S, Kamura T, Shibuya T, Harada M and Niho Y. (1992). Acquired von Willebrand's disease in association with essential thrombocythemia: Regression following treatment. Acta Haematologica. 87:83-87.
Nam KY and Park JD. (2000). Usage and dosage of ginseng radix based upon traditional and recent scientific clinical applications. Journal of Ginseng Research. 24:99-105.
Park CK, Kwak YS, Hwang MS, Kim SC and Do JH. (2007). Current status of ginseng products in market of health functional food. The Korean Ginseng Research and Industry. 1:9-16.
이 논문을 인용한 문헌
저자의 다른 논문 :
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
활용도 분석정보
상세보기
다운로드
내보내기
활용도 Top5 논문
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다. 더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.